Gear Up for Health Catalyst (HCAT) Q4 Earnings: Wall Street Estimates for Key Metrics

Core Insights - Health Catalyst (HCAT) is expected to report quarterly earnings of $0.10 per share, marking a 150% increase year-over-year, while revenues are forecasted at $73.61 million, reflecting a 7.5% decrease compared to the previous year [1] - The consensus EPS estimate has remained unchanged over the past 30 days, indicating analysts' reassessment of their projections [1] Revenue Estimates - The consensus estimate for 'Revenue- Professional services' is $22.88 million, indicating an 18.3% decline from the same quarter last year [4] - Analysts project 'Revenue- Technology' to be $50.74 million, suggesting a year-over-year decrease of 1.7% [4] Profit Estimates - The estimated 'Adjusted Gross Profit- Professional Services' is projected to reach $4.22 million, an increase from $3.78 million in the same quarter last year [4] - For 'Adjusted Gross Profit- Technology', the estimate stands at $34.30 million, compared to $33.35 million reported in the same quarter last year [5] Stock Performance - Over the past month, shares of Health Catalyst have declined by 9.3%, while the Zacks S&P 500 composite has decreased by 2.7% [5] - Health Catalyst currently holds a Zacks Rank 2 (Buy), indicating potential outperformance in the near future [5]